PIK3CA and cancer: In contrast, activating PIK3CA gene alterations, present in 18 cases (2% of the entire cohort), were distributed across cancer diagnoses with 6 different extracranial solid tumors and 5 different CNS solid tumor diagnoses containing these alterations.